Latest Debt Facilities News

N1 Holdings reports a profitable FY2025 with strategic expansion into Australia's largest aggregator panel and launches AI-driven credit tools to enhance SME lending operations.

Minbos Resources has secured key financing and made significant construction strides on its Angolan phosphate fertilizer plant, while rolling out promising new fertilizer blends to support local agriculture.

First Lithium Limited is on the cusp of securing critical mining license renewals in Mali and anticipates releasing its maiden Mineral Resource Estimate this quarter, while managing funding and exploration cost pressures.

Arafura Rare Earths pushes forward with equity funding for its Nolans Project, targeting a €100 million investment from Germany’s Raw Materials Fund amid rising geopolitical tensions reshaping the rare earths landscape.

BCI Minerals reports solid progress on its Mardie Salt Operation with 69% construction complete and commissioning of the first crystallisers, advancing towards first salt shipment by late 2026.

Beforepay Group Limited reported a record Q4 FY25 with a 76% increase in net profit before tax, driven by strong revenue growth and strategic U.S. partnerships through Carrington Labs.

Peninsula Energy reported a $5.3 million operating cash outflow for the June quarter and secured a $15 million debt facility to advance its Lance Project toward uranium production, expected by August 2025.

Peninsula Energy advances commissioning at its Lance uranium project, resets most sales contracts to reduce risk, and secures a $15 million debt facility to support production ramp-up.

Bowen Coking Coal reported record operating cashflows of $19.1 million in the June 2025 quarter, achieving all FY2025 guidance despite heavy rains and logistical hurdles. The company has launched a low-cost mining strategy while negotiating liquidity solutions amid depressed coal prices.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.